No connection

Search Results

Analysis Neutral

Biotech Fund BVF Trims MoonLake Stake, Sells $63M in Shares

Apr 07, 2026 18:27 UTC

Key PointsBVF sold 3,750,000 shares for a transaction value of approximately $62.96 million on April 2, 2026..

  • April 07, 2026 — 02:27 pm EDT Written byPamela KockforThe Motley Fool-> BVF sold 3,750,000 shares for a transaction value of approximately $62
  • 96 million on April 2, 2026
  • The sale represented 78

April 07, 2026 — 02:27 pm EDT Written byPamela KockforThe Motley Fool-> BVF sold 3,750,000 shares for a transaction value of approximately $62.96 million on April 2, 2026. The sale represented 78.30% of BVF's direct holdings, reducing direct ownership to 1,039,238 shares. All shares were sold from direct holdings; no indirect or derivative shares were involved in this transaction. On April 2, 2026,MoonLake Immunotherapeutics(NASDAQ:MLTX)BVF Partners L.P. reported the direct sale of 3,750,000 shares of Common Stock for a total consideration of approximately $62.96 million, according to aSEC For

Sign up free to read the full analysis

Create a free account to unlock full AI-curated market articles, personalized alerts, and more.

Create Free Account Already have an account? Sign In
Share this article

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.

Get Started Free View Plans
Features Terminal AI Assistant Analysis Market News Pricing
Start Trading with AI Already have an account? Sign In
Home
Terminal
AI
Markets
Profile